These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 2904752

  • 1. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T, Westlie L, Daae L, Vatle S.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
    Mazzola C, Guerrasio E.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1797-801. PubMed ID: 2904753
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH, Cox DA, Himanen P, Huttunen M, Pitkäjärvi T, Pörsti P, Pöyhönen L, Pyykönen ML, Reinikainen P, Salmela P.
    Am J Cardiol; 1987 May 29; 59(14):61G-67G. PubMed ID: 2884854
    [Abstract] [Full Text] [Related]

  • 7. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT, Schonfeld G, Reeves RL, Black H, Weidler DJ.
    Am J Cardiol; 1987 May 29; 59(14):87G-90G. PubMed ID: 2884859
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
    Daae LN, Westlie L.
    Blood Press; 1998 Jan 29; 7(1):39-45. PubMed ID: 9551876
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with doxazosin in general medical practice.
    Rosenthal J.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1748-57. PubMed ID: 2904745
    [Abstract] [Full Text] [Related]

  • 11. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P, Fagard R, Staessen J, Lissens W, Amery A.
    J Cardiovasc Pharmacol; 1989 Aug 29; 14(2):319-25. PubMed ID: 2476608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct 29; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 18. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W, Berger J, Blumrich W, Bouzo H, Brandl K, Braun S, Laukaitis A, Müller G, Ryba W, Schreiegg J.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Dec 29; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.